|
1.
|
NAME
OF REPORTING PERSON
S.S.
OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Midsummer
Investment Ltd.
|
||
|
2.
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) o
(b) x
|
||
|
3.
|
SEC
USE ONLY
|
||
|
4.
|
CITIZENSHIP
OR PLACE OF ORGANIZATION:
Bermuda
|
||
|
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
5.
|
SOLE
VOTING POWER
8,661,136
|
|
|
6.
|
SHARED
VOTING POWER
None.
|
||
|
7.
|
SOLE
DISPOSITIVE POWER
8,661,136
|
||
|
8.
|
SHARED
DISPOSITIVE POWER
None.
|
||
|
9.
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
8,661,136
|
||
|
10.
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES
o
|
||
|
11.
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.3%
(1)
|
||
|
12.
|
TYPE
OF REPORTING PERSON:
OO
|
||
|
Item
1(a).
|
Name
of Issuer.
|
|
Elite
Pharmaceuticals, Inc. (the “Issuer”)
|
|
|
Item
1(b).
|
Address
of Issuer’s Principal Executive Offices.
|
|
165
Ludlow Avenue, Northvale, New Jersey 07647
|
|
|
Item
2(a).
|
Names
of Person Filing.
|
|
Midsummer
Investment Ltd. (“Midsummer
Investment”)
|
|
Item
2(b).
|
Address
of Principal Business Office, or if none, Residence.
|
|
Midsummer
Investment Ltd.
c/o
Midsummer Capital, LLC
295
Madison Ave, 38th
Floor
New
York, NY 10017
|
|
|
Item
2(c).
|
Citizenship
or Place of Organization.
|
|
Bermuda
|
|
|
Item
2(d).
|
Title
of Class of Securities.
|
|
Common
Stock, $0.001 par value (the “Common
Stock”)
|
|
|
Item
2(e).
|
CUSIP
Number.
|
|
28659T200
|
|
|
Item
3.
|
If
this statement is filed pursuant to Rules 13d-1(b) or 13d-2(b), check
whether the person filing is a:
|
|
Not
applicable.
|
|
|
Item
4.
|
Ownership.
|
|
Accordingly,
for the purpose of this Statement:
|
|||
|
(a)
|
Amount
beneficially owned by Midsummer Investment: 8,661,136 shares of Common Stock of the
Issuer.
|
||
|
(b)
|
Percent
of Class: Midsummer Investment beneficially owns 9.3% of the Issuer’s issued and
outstanding Common Stock (based on 92,656,745 shares of Common Stock
issued and outstanding as of July
9, 2010 as stated in writing by the Issuer’s Chief Financial Officer on
July 12, 2010).
|
||
|
(c)
|
Number
of shares as to which Midsummer Investment has:
|
||
|
(i)
|
Sole
power to direct the vote: 8,661,136 shares of Common Stock of the
Issuer.
|
||
|
(ii)
|
Shared
power to vote or to direct the vote: None.
|
||
|
(iii)
|
Sole
power to dispose or direct the disposition of the Common Stock: 8,661,136
shares of Common Stock of the Issuer.
|
||
|
|
(iv)
|
Shared
power to dispose or direct the disposition of the Common Stock:
None.
|
|
|
Item
5.
|
Ownership
of Five Percent or Less of a Class.
|
|
Not
applicable.
|
|
|
Item
6.
|
Ownership
of More than Five Percent on Behalf of Another Person.
|
|
Not
applicable.
|
|
|
Item
7.
|
Identification
and Classification of the Subsidiary Which Acquired the Security Being
Reported on By the Parent Holding Company.
|
|
Not
applicable.
|
|
|
Item
8.
|
Identification
and Classification of Members of the Group.
|
|
Not
applicable.
|
|
|
Item
9.
|
Notice
of Dissolution of Group.
|
|
Not
applicable.
|
|
|
Item
10.
|
Certification.
|
|
By
signing below, I certify that, to the best of my knowledge and belief, the
securities referred to above were not acquired and are not held for the
purpose of or with the effect of changing or influencing the control of
the issuer of the securities and were not acquired and are not held in
connection with or as a participant in any transaction which could have
that purpose or effect.
|
|
Date: July
12, 2010
|
|||
|
MIDSUMMER
INVESTMENT LTD.
|
|||
|
By:
|
/s/ Michel A. Amsalem
|
||
|
Name:
Michel A. Amsalem
|
|||
|
Title: President
|
|||